Pages that link to "Q33614233"
Jump to navigation
Jump to search
The following pages link to Changing epidemiological features of cardiac failure (Q33614233):
Displaying 50 items.
- Epidemiology and risk profile of heart failure (Q24630778) (← links)
- Aortic wave dynamics and its influence on left ventricular workload (Q28741508) (← links)
- Myocardial Contrast Echocardiography in the Evaluation of Hypertensive Heart Disease. (Q30360279) (← links)
- Cost effectiveness of bisoprolol in the treatment of chronic congestive heart failure in Sweden: analysis using data from the Cardiac Insufficiency Bisoprolol Study II trial (Q30665281) (← links)
- N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF). (Q30908647) (← links)
- Correlation of the Agency for Health Care Policy and Research congestive heart failure admission guideline with mortality: peer review organization voluntary hospital association initiative to decrease events (PROVIDE) for congestive heart failure. (Q33145004) (← links)
- Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry (Q33395934) (← links)
- Drug-induced heart failure (Q33588565) (← links)
- Risk factors for heart failure in the elderly: a prospective community-based study (Q33667197) (← links)
- Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing (Q33761562) (← links)
- Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease (Q33846667) (← links)
- The heart failure epidemic (Q33858952) (← links)
- Vital epidemiologic clues in heart failure (Q33889155) (← links)
- Epidemiology, aetiology, and prognosis of heart failure (Q33893882) (← links)
- Manipulating survival and life quality outcomes in heart failure through disease state management. (Q33934467) (← links)
- Towards a blood test for heart failure: the potential use of circulating natriuretic peptides (Q33962030) (← links)
- Advances in the treatment of congestive heart failure: new approaches for an old disease (Q33977639) (← links)
- Clinical manifestations, diagnostic assessment, and etiology of heart failure in elderly patients (Q33986271) (← links)
- Regional left ventricular myocardial dysfunction as a predictor of incident cardiovascular events MESA (multi-ethnic study of atherosclerosis). (Q34014145) (← links)
- Current status of the epidemiology of heart failure (Q34027168) (← links)
- Defects in insulin action in chronic heart failure (Q34166305) (← links)
- Patients with worsening chronic heart failure who present to a hospital emergency department require hospital care (Q34188615) (← links)
- New epidemiologic perspectives concerning mild-to-moderate heart failure (Q34239859) (← links)
- Implications of recent heart failure trials for patients with hypertension (Q34401857) (← links)
- The looming polypharmacy crisis in the management of patients with heart failure. Potential solutions (Q34443705) (← links)
- Epidemiology of heart failure (Q34443713) (← links)
- The burden of chronic congestive heart failure in older persons: magnitude and implications for policy and research (Q34493498) (← links)
- Opportunities for improvement in the diagnosis and treatment of heart failure (Q35137098) (← links)
- Preventable causative factors leading to hospital admission with decompensated heart failure (Q35369642) (← links)
- Survival differences between heart failure in general practices and in hospitals. (Q35574257) (← links)
- Left ventricular dysfunction: causes, natural history, and hopes for reversal (Q35578952) (← links)
- Trends in comorbidity, disability, and polypharmacy in heart failure (Q35611459) (← links)
- Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis. (Q35678102) (← links)
- Diastolic heart failure: the forgotten manifestation of hypertensive heart disease (Q35765134) (← links)
- Gender and heart failure: a population perspective (Q35771154) (← links)
- Hypertension and heart failure: role of neurohormonal mechanisms (Q36035785) (← links)
- Angiotensin II-receptor antagonist in the treatment of hypertension (Q36214898) (← links)
- Incidence and epidemiology of heart failure (Q36287940) (← links)
- Metabolic and immunologic derangements in cardiac cachexia: where to from here? (Q36526900) (← links)
- Residential exposure to traffic-related air pollution and survival after heart failure (Q36535063) (← links)
- Hypertension and heart failure: diagnosis and management (Q36674315) (← links)
- Primary and secondary prevention of heart failure with statins (Q36686069) (← links)
- Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study (Q36693904) (← links)
- Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes (Q36715249) (← links)
- Assessing the Global Burden of Ischemic Heart Disease: Part 1: Methods for a Systematic Review of the Global Epidemiology of Ischemic Heart Disease in 1990 and 2010 (Q36839088) (← links)
- Heart failure in South Asia (Q36928506) (← links)
- The relationship between body mass index/body composition and survival in patients with heart failure. (Q37202909) (← links)
- Genesis and regulation of the heart automaticity. (Q37216067) (← links)
- Epidemiology of Heart Failure in Korea: Present and Future (Q37318509) (← links)
- Risk factors for heart failure: a population-based case-control study (Q37462115) (← links)